In the pharma industry, there are blockbuster drugs and—for the truly fortunate companies—mega blockbusters. However, Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro are in a category all to themselves, which is confounding analysts trying to get a handle on their potential market size amid the frenzied demand for these weight-loss medicines.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,